Ahmed Emad Ali, El-Badry Ashraf Mohammad, Mocchegiani Federico, Montalti Roberto, Hassan Asem Elsani Ali, Redwan Alaa Ahmed, Vivarelli Marco
Division of Hepatobiliary and Abdominal Transplantation Surgery, Department of Experimental and Clinical Medicine, Polytechnic University of Marche, Ancona, Italy.
Division of Hepatobiliary and Pancreatic Surgery Unit, Department of General Surgery, University of Sohag, Sohag, Egypt.
Surg J (N Y). 2018 Oct 18;4(4):e188-e196. doi: 10.1055/s-0038-1675236. eCollection 2018 Oct.
Steatotic grafts are more susceptible to ischemia-reperfusion injury than are normal grafts. Therefore, using steatotic grafts for liver transplantation (LT) is associated with high primary dysfunction and decreased survival rates. The aim of this study is to evaluate the impact of graft steatosis on post LT outcomes. A retrospective cohort analysis of 271 LT recipients from 2005 to 2016 was performed and patients were classified based on two types of steatosis, macrosteatosis (MaS), and microsteatosis (MiS). Each category was subdivided into three groups according to the degree of steatosis: no (< 5%), mild (≥5 to < 30%), and moderate (≥30 to ≤60%). The primary hospital stays and 6-month postoperative complications were analyzed by the Clavien-Dindo classification system. Additionally, patient and graft survivals were studied. Significant differences were observed in grade III MaS ( -value = 0.019) and grade V MiS ( -value = 0.020). A high trend of early graft dysfunction was found in the moderate MaS and MiS groups; however, they were not statistically significant ( -value = 0.199 and 0.282, respectively). Interestingly, the acute cellular rejection (ACR) rate was found to be inversely proportional to the degree of steatosis in both categories but it did not reach a significant level ( -value = 0.161 and 0.111, respectively). Excellent post LT long-term outcomes using grafts with mild and moderate steatosis were determined. Further studies are needed to evaluate the newly proposed relationship between ACR and steatosis.
脂肪变性的移植物比正常移植物更容易受到缺血再灌注损伤。因此,使用脂肪变性的移植物进行肝移植(LT)会导致较高的原发性功能障碍和较低的生存率。本研究的目的是评估移植物脂肪变性对肝移植术后结局的影响。
对2005年至2016年的271例肝移植受者进行了回顾性队列分析,并根据两种脂肪变性类型,即大泡性脂肪变性(MaS)和小泡性脂肪变性(MiS)对患者进行分类。每个类别根据脂肪变性程度细分为三组:无(<5%)、轻度(≥5%至<30%)和中度(≥30%至≤60%)。采用Clavien-Dindo分类系统分析主要住院时间和术后6个月的并发症。此外,还研究了患者和移植物的生存率。
在III级MaS(P值 = 0.019)和V级MiS(P值 = 0.020)中观察到显著差异。在中度MaS和MiS组中发现早期移植物功能障碍有升高趋势;然而,它们没有统计学意义(P值分别为0.199和0.282)。有趣的是,发现急性细胞排斥反应(ACR)率在这两种类型中均与脂肪变性程度成反比,但未达到显著水平(P值分别为0.161和0.111)。
确定了使用轻度和中度脂肪变性移植物的肝移植术后长期结局良好。需要进一步研究来评估新提出的ACR与脂肪变性之间的关系。